NM_145038.5:c.1418C>T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_145038.5(DRC1):​c.1418C>T​(p.Ala473Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000237 in 1,614,200 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A473D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00034 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 1 hom. )

Consequence

DRC1
NM_145038.5 missense

Scores

3
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5B:1

Conservation

PhyloP100: -1.94

Publications

3 publications found
Variant links:
Genes affected
DRC1 (HGNC:24245): (dynein regulatory complex subunit 1) This gene encodes a central component of the nexin-dynein complex (N-DRC), which regulates the assembly of ciliary dynein. Mutations in this gene can cause ciliary dyskinesia. [provided by RefSeq, Aug 2015]
DRC1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 21
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • spermatogenic failure 80
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010977119).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000226 (331/1461868) while in subpopulation MID AF = 0.00781 (45/5760). AF 95% confidence interval is 0.006. There are 1 homozygotes in GnomAdExome4. There are 174 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC1NM_145038.5 linkc.1418C>T p.Ala473Val missense_variant Exon 11 of 17 ENST00000288710.7 NP_659475.2
DRC1XM_047446339.1 linkc.398C>T p.Ala133Val missense_variant Exon 4 of 10 XP_047302295.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DRC1ENST00000288710.7 linkc.1418C>T p.Ala473Val missense_variant Exon 11 of 17 2 NM_145038.5 ENSP00000288710.2
DRC1ENST00000439066.2 linkn.148C>T non_coding_transcript_exon_variant Exon 2 of 5 3
DRC1ENST00000649059.1 linkn.*381C>T non_coding_transcript_exon_variant Exon 10 of 16 ENSP00000497543.1
DRC1ENST00000649059.1 linkn.*381C>T 3_prime_UTR_variant Exon 10 of 16 ENSP00000497543.1

Frequencies

GnomAD3 genomes
AF:
0.000335
AC:
51
AN:
152214
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000367
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000290
AC:
73
AN:
251452
AF XY:
0.000294
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000231
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000281
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000226
AC:
331
AN:
1461868
Hom.:
1
Cov.:
33
AF XY:
0.000239
AC XY:
174
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.000508
AC:
17
AN:
33478
American (AMR)
AF:
0.000313
AC:
14
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53420
Middle Eastern (MID)
AF:
0.00781
AC:
45
AN:
5760
European-Non Finnish (NFE)
AF:
0.000151
AC:
168
AN:
1112006
Other (OTH)
AF:
0.000596
AC:
36
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000341
AC:
52
AN:
152332
Hom.:
1
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41578
American (AMR)
AF:
0.000653
AC:
10
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.000367
AC:
25
AN:
68032
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000369
Hom.:
0
Bravo
AF:
0.000310
ExAC
AF:
0.000338
AC:
41
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000652

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Aug 21, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The A473V variant in the DRC1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A473V variant is observed in 29/66,340 (0.043%) alleles from individuals of European (non-Finnish) background in the ExAC dataset (Lek et al., 2016). The A473V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret A473V as a variant of uncertain significance.

Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

Inborn genetic diseases Uncertain:1
Sep 27, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1418C>T (p.A473V) alteration is located in exon 11 (coding exon 11) of the DRC1 gene. This alteration results from a C to T substitution at nucleotide position 1418, causing the alanine (A) at amino acid position 473 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Primary ciliary dyskinesia Uncertain:1
Aug 09, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 473 of the DRC1 protein (p.Ala473Val). This variant is present in population databases (rs199574440, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with DRC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 407102). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Primary ciliary dyskinesia 21 Uncertain:1
Jan 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DRC1-related disorder Benign:1
Feb 06, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.32
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0020
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.95
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
-1.9
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.4
N
Sift
Uncertain
0.026
D
Sift4G
Benign
0.12
T
Vest4
0.26
ClinPred
0.021
T
GERP RS
-0.71
Varity_R
0.059
gMVP
0.22
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199574440; hg19: chr2-26671580; API